Interleukin-2 fusion protein(United Laboratories International)
白介素-2融合蛋白（联邦制药国际）
Report date: 2025/12/12 17:26:22
Base Information
Drug NameInterleukin-2 fusion protein(United Laboratories International)
Drug Alias NameN/A
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesUnited Laboratories International Holdings Limited -The-
China Registration ClassN/A
Develop Information
Active CompaniesUnited Laboratories International Holdings Limited -The-
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A